N-Ethyl-lanicemine

N-Ethyl-lanicemine
	Structural diagram of N-ethyl-lanicemine
Names
	IUPAC name N-ethyl-1-phenyl-2-pyridin-2-ylethanamine
	Other names Ethyl[1-phenyl-2-(pyridin-2-yl)ethyl]amine
Identifiers
3D model (JSmol)	Interactive image;
ChemSpider	38343049;
PubChem CID	60818702;
	InChI InChI=1S/C15H18N2/c1-2-16-15(13-8-4-3-5-9-13)12-14-10-6-7-11-17-14/h3-11,15-16H,2,12H2,1H3 Key: SPBDLAUONJHXNB-UHFFFAOYSA-N;
	SMILES CCNC(CC1=CC=CC=N1)C2=CC=CC=C2;
Properties
Chemical formula	C15H18N2
Molar mass	226.323 g·mol−1
Related compounds
Related compounds	lanicemine
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

N-Ethyl-lanicemine (or ethyl[1-phenyl-2-(pyridin-2-yl)ethyl]amine) is an analogue of lanicemine and a designer drug^[1] that has been sold online due to being a high trapping NMDAR antagonist and having possible PCP-like effects in humans. It is in the 1,2-diarylethylanime class of dissociatives.^[2] ^[3]

References

↑ PubChem. "ethyl[1-phenyl-2-(pyridin-2-yl)ethyl]amine HCl, N-ethyl-lanicemine HCl". pubchem.ncbi.nlm.nih.gov. Retrieved 2026-04-11.
↑ Wallach, Jason; Brandt, Simon D. (2018). "1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances". Handbook of Experimental Pharmacology. 252: 305–352. doi:10.1007/164_2018_148. ISBN 978-3-030-10560-0. ISSN 0171-2004. PMID 30196446.{{cite journal}}: CS1 maint: periodical has ISBN (link)
↑ Mealing, G. A.; Lanthorn, T. H.; Small, D. L.; Murray, R. J.; Mattes, K. C.; Comas, T. M.; Morley, P. (June 2001). "Structural modifications to an N-methyl-D-aspartate receptor antagonist result in large differences in trapping block". The Journal of Pharmacology and Experimental Therapeutics. 297 (3): 906–914. doi:10.1016/S0022-3565(24)29614-2. ISSN 0022-3565. PMID 11356910.

[1] PubChem. "ethyl[1-phenyl-2-(pyridin-2-yl)ethyl]amine HCl, N-ethyl-lanicemine HCl". pubchem.ncbi.nlm.nih.gov. Retrieved 2026-04-11.

[2] Wallach, Jason; Brandt, Simon D. (2018). "1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances". Handbook of Experimental Pharmacology. 252: 305–352. doi:10.1007/164_2018_148. ISBN 978-3-030-10560-0. ISSN 0171-2004. PMID 30196446.{{cite journal}}: CS1 maint: periodical has ISBN (link)

[3] Mealing, G. A.; Lanthorn, T. H.; Small, D. L.; Murray, R. J.; Mattes, K. C.; Comas, T. M.; Morley, P. (June 2001). "Structural modifications to an N-methyl-D-aspartate receptor antagonist result in large differences in trapping block". The Journal of Pharmacology and Experimental Therapeutics. 297 (3): 906–914. doi:10.1016/S0022-3565(24)29614-2. ISSN 0022-3565. PMID 11356910.

[1]

[2]

[3]